STOCK TITAN

Freenome (FRNM) Stock Price, News & Analysis

FRNM NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
8 34 sessions, July 21, 2026 to September 4, 2026
Largest daily move
+12.5% close of August 17, 2026

Company Description

Freenome (NASDAQ: FRNM) is classified in the diagnostics & research industry within the Services-medical Laboratories sector and carries a market capitalization of $1.8B, ranking #2,452 among all listed U.S. companies by market cap.

FRNM has gained 49.5% over the past month. Shares last traded at $16.31.

For FY2025, Freenome reported net income of $837K.

This page collects what Stock Titan holds for FRNM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
+49.5%
Performance 1 month

Freenome (FRNM) stock last closed at $16.31. Over the past month, the stock has gained 49.5%. At a market capitalization of $1.8B, FRNM is classified as a small-cap stock with approximately 107.4M shares outstanding.

See what a $1,000 investment in FRNM would be worth today

Latest News

Freenome has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include fda approval. View all FRNM news →

SEC Filings

Freenome has filed 5 recent SEC filings, including 1 Form 4, 1 Form SCHEDULE 13G, 1 Form EFFECT, 1 Form 424B3. The most recent filing was submitted on September 4, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all FRNM SEC filings →

Financial Highlights

operating income reached -$3.0M, and net income was $837K. The company generated -$865K in operating cash flow. With a current ratio of 0.40, short-term liquidity bears monitoring.

$837K
Net Income (FY2025)
-$865K
Operating Cash Flow
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Freenome (FRNM) currently stands at 1.4 million shares, up 217.8% from the previous reporting period, representing 2.1% of the float. Since July 2026, short interest has increased by 217.8%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Freenome (FRNM) currently stands at 1.8 days, up 75% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 75% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.8 days.

FRNM Company Profile & Sector Positioning

Freenome (FRNM) operates in the Diagnostics & Research industry within the broader Services-medical Laboratories sector and is listed on the NASDAQ. In monthly performance, the stock ranks #359 among all tracked companies.

Frequently Asked Questions

What is the current stock price of Freenome (FRNM)?

The current stock price of Freenome (FRNM) is $16.31 as of September 4, 2026.

What is the market cap of Freenome (FRNM)?

The market cap of Freenome (FRNM) is approximately 1.8B. Learn more about what market capitalization means .

What is the net income of Freenome (FRNM)?

The FY2025 net income of Freenome (FRNM) is $837K, from its most recent completed fiscal year.

What is the operating cash flow of Freenome (FRNM)?

The operating cash flow of Freenome (FRNM) is -$865K. Learn about cash flow.

What is the current ratio of Freenome (FRNM)?

The current ratio of Freenome (FRNM) is 0.40, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Freenome (FRNM)?

The operating income of Freenome (FRNM) is -$3.0M. Learn about operating income.